SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 29 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,651,655 | +2.2% | 168,193 | -42.8% | 0.04% | +18.9% |
| Q2 2023 | $1,616,412 | -9.8% | 293,893 | +1.6% | 0.04% | -2.6% |
| Q1 2023 | $1,792,780 | +38865.0% | 289,158 | -4.2% | 0.04% | -61.6% |
| Q4 2022 | $4,601 | -99.8% | 301,690 | +43.7% | 0.10% | +115.2% |
| Q3 2022 | $2,106,000 | -16.0% | 209,886 | -0.7% | 0.05% | -6.1% |
| Q2 2022 | $2,506,000 | -24.1% | 211,460 | +21.7% | 0.05% | -80.3% |
| Q1 2022 | $3,301,000 | -45.7% | 173,725 | -31.7% | 0.25% | -42.6% |
| Q4 2021 | $6,080,000 | – | 254,519 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |